TransMedics Group (NASDAQ: TMDX) reported Q1 EPS of $0.30, $0.32 worse than the analyst estimate of $0.62. Revenue for the quarter came in at $173.9 million versus the consensus estimate of $174.47 million.

GUIDANCE:

TransMedics Group sees FY2026 revenue of $727-757 million, versus the consensus of $739 million.

For earnings history and earnings-related data on TransMedics Group (TMDX) click here.